# Sika Interplant Systems (NSE: SIKA) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/SIKA · Pivot · prices to 22 Oct 2026

Sika Interplant Systems (NSE: SIKA) closed at ₹894.90 on 22 Oct 2026, down 1.17% on the day. With a market capitalisation of ₹1,897 Cr, it ranks 1165th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Diversified sector.

Its return on equity was 23.4% in FY26. Its 52-week range is ₹870.10 (18 May 2026) to ₹1,359.40 (3 Jul 2026); the last close is 34.2% below the high. In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹41 Cr (−10.2% year on year) and net profit ₹8 Cr (−1.1%), on a consolidated basis. Promoters held 71.72% of the company as of 30 Jun 2026.

## Key numbers

| Metric | Value |
| --- | --- |
| Last close | ₹894.90 |
| Market cap | ₹1,897 Cr |
| ROE | 23.4% (FY26) |
| ROCE | 30.6% (FY26) |
| Debt to equity | 0 |
| 52-week high | ₹1,359.40 (3 Jul 2026) |
| 52-week low | ₹870.10 (18 May 2026) |

## Quarterly results (₹ crore, consolidated)

| Quarter | Revenue | Revenue YoY | Net profit | Net profit YoY | EPS (₹) |
| --- | --- | --- | --- | --- | --- |
| Q4 FY26 | ₹41 Cr | −10.2% | ₹8 Cr | −1.1% | ₹3.72 |
| Q3 FY26 | ₹50 Cr | +32.5% | ₹9 Cr | +32.9% | ₹4.48 |
| Q2 FY26 | ₹52 Cr | +55.2% | ₹9 Cr | +44.4% | ₹4.22 |
| Q1 FY26 | ₹68 Cr | +123.6% | ₹10 Cr | +96.4% | ₹4.88 |
| Q4 FY25 | ₹46 Cr | +23.8% | ₹8 Cr | +30.7% | ₹3.73 |
| Q3 FY25 | ₹38 Cr | +46.1% | ₹7 Cr | +51.0% | ₹16.85 |
| Q2 FY25 | ₹33 Cr | +82.0% | ₹6 Cr | +23.6% | ₹14.59 |
| Q1 FY25 | ₹30 Cr | +23.6% | ₹5 Cr | +47.6% | ₹12.42 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY25 | ₹148 Cr | ₹25 Cr |
| FY24 | ₹106 Cr | ₹19 Cr |
| FY23 | ₹60 Cr | ₹9 Cr |
| FY22 | ₹98 Cr | ₹17 Cr |
| FY21 | ₹80 Cr | ₹12 Cr |
| FY20 | ₹63 Cr | ₹7 Cr |

## Shareholding (30 Jun 2026)

- Promoters: 71.72%
- Foreign institutions: 3.25%
- Domestic institutions: 0.04%
- Non-institutions: 24.99%

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [BOMDYEING](https://app.pivotnow.in/stock/BOMDYEING) | ₹92.13 | ₹1,903 Cr | — | — |
| [Grand Oak Canyons Distillery](https://app.pivotnow.in/stock/GRANDOAK) | ₹35.48 | ₹1,841 Cr | — | — |
| [Kothari Industrial Corporation](https://app.pivotnow.in/stock/KOTIC) | ₹133.76 | ₹1,445 Cr | — | — |
| [Fedders Holding](https://app.pivotnow.in/stock/FEDDERSHOL) | ₹57.00 | ₹1,148 Cr | — | — |
| [3B Blackbio Dx](https://app.pivotnow.in/stock/3BBLACKBIO) | ₹1,316.60 | ₹1,130 Cr | — | — |
| [Safe Enterprise](https://app.pivotnow.in/stock/SAFEENTP) | ₹227.20 | ₹1,059 Cr | — | — |

## Questions and answers

### What is the share price of Sika Interplant Systems today?

Sika Interplant Systems (NSE: SIKA) last closed at ₹894.90 on 22 Oct 2026. Its 52-week high is ₹1,359.40 and its 52-week low is ₹870.10.

### What is the market cap of Sika Interplant Systems?

Sika Interplant Systems' market capitalisation is ₹1,897 Cr (₹1,897 Cr) at the 22 Oct 2026 close, ranking 1165th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Sika Interplant Systems?

Return on equity was 23.4% in FY26 and return on capital employed was 30.6% in FY26 (consolidated figures).

### Is Sika Interplant Systems a debt-free company?

Sika Interplant Systems is close to debt-free: its debt-to-equity ratio was 0 in FY26.

### What were Sika Interplant Systems' latest quarterly results?

For Q4 FY26 (quarter ended 31 Mar 2026), Sika Interplant Systems reported revenue of ₹41 Cr, −10.2% year on year, and net profit of ₹8 Cr, −1.1% year on year.

### What is the shareholding pattern of Sika Interplant Systems?

As of 30 Jun 2026: promoters 71.72%, foreign institutions 3.25%, domestic institutions 0.04%, non-institutions 24.99%.

### Who are Sika Interplant Systems' competitors?

The listed Diversified companies closest to Sika Interplant Systems by market cap are BOMDYEING, Grand Oak Canyons Distillery, Kothari Industrial Corporation, Fedders Holding, 3B Blackbio Dx and Safe Enterprise.

### Is Sika Interplant Systems a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Sika Interplant Systems' price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on SIKA against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.